Tom Beauvironnet

Investment Manager

Catherine Boule

Managing Partner

Luca Brilliet

Investment Manager

Emmanuel Daugeras

Investment Director

Olivier Dubuisson

Managing Partner

Baudouin Hue

Partner

Jérôme Snollaerts

President

Benjamin Zerbib

Investment Director

Yvan-Michel Ehkirch

Managing Partner

Past deals in France

Exotrail

Series B in 2023
Exotrail specializes in electric propulsion solutions for small satellites, providing advanced Hall Effect Thrusters designed to enhance the agility and efficiency of satellite constellations. Founded in 2015 by David Henri, Jean-Luc Maria, Paul Lascombes, and Nicolas Heitz in Palaiseau, Ile-de-France, the company aims to revolutionize sectors such as telecommunications, earth observation, and space science. Exotrail's technology allows for greater flexibility in satellite deployment, enabling clients to access new orbits, extend operational lifespans, and optimize service performance. The company's focus on small satellite propulsion contributes to reducing space pollution while facilitating more effective satellite operations in orbit.

Ludocare

Seed Round in 2022
Ludocare is to create ways to provide assistance to patients and their families to improve their abilities, autonomy, and quality of life.

Vestack

Series A in 2022
Vestack is a PropTech company specializing in the design and manufacture of low-carbon buildings constructed from bio-sourced materials. By utilizing a modular construction system, Vestack offers flexible solutions for various applications, including residential and public buildings, while accommodating diverse architectural styles and land plot constraints. The company integrates proprietary software and hardware technology to promote the construction of healthy and sustainable structures, ensuring rapid production and cost-effectiveness for project developers. Acting as a general contractor, Vestack collaborates with real estate developers to deliver innovative, environmentally friendly building solutions.

Leanspace

Seed Round in 2022
Today, space organizations need to build and manage increasingly complex ground software infrastructures: to design, integrate and operate their assets. To do so, they can rely on off-the-shelf systems (COTS) but lose control over their tools, or build everything from scratch which is slow and consumes lots of resources. Leanspace brings a new way to build space software. We provide all the generic functions, easily consumable as-a-service, via APIs. The platform enables organizations to build all their systems in-house, but only developing the functionalities they need. This drastically reduces time & costs, keeps them in control, and boosts competitiveness. Leanspace-powered systems are integrated, collaborative and digital. Don’t reinvent the wheel, transform your business!

Implicity

Series A in 2022
Implicity is a developer of a remote monitoring platform that specializes in the smart monitoring of patients with connected cardiac devices, such as pacemakers and defibrillators. The platform utilizes artificial intelligence to sort and summarize patient data, assessing the criticality of alerts based on individual medical contexts. This capability allows cardiologists and healthcare professionals to automate the monitoring process, enabling them to effectively oversee patient health while consolidating information on a single platform. By streamlining remote monitoring, Implicity aims to enhance the quality of care provided to patients with cardiac implants.

Humanlinker

Seed Round in 2022
Shaping the future of revenue generation. Humanlinker is a cutting-edge AI guided technology for revenue generation teams

Sitowie

Seed Round in 2022
Sitowie develops SaaS technology and tools to understand the degradation of buildings. Sitowie assists real estate decision-makers in the public and private sectors with sustainable building management in order to increase profitability, reduce carbon emissions, reduce energy consumption, and improve energy resilience. They offer a practical solution for firms managing a real estate portfolio, regardless of their level of data maturity.

i-Lunch

Series A in 2021
i-Lunch offers corporate catering services. I-Lunch provides businesses with adaptable, high-demand, and customized solutions. I-online Lunch's ordering platform offers useful and delectable recipes that are prepared in returnable glass containers and developed jointly by the company's nutritionists and chefs.

Vestack

Series A in 2021
Vestack is a PropTech company specializing in the design and manufacture of low-carbon buildings constructed from bio-sourced materials. By utilizing a modular construction system, Vestack offers flexible solutions for various applications, including residential and public buildings, while accommodating diverse architectural styles and land plot constraints. The company integrates proprietary software and hardware technology to promote the construction of healthy and sustainable structures, ensuring rapid production and cost-effectiveness for project developers. Acting as a general contractor, Vestack collaborates with real estate developers to deliver innovative, environmentally friendly building solutions.

Exotrail

Series A in 2020
Exotrail specializes in electric propulsion solutions for small satellites, providing advanced Hall Effect Thrusters designed to enhance the agility and efficiency of satellite constellations. Founded in 2015 by David Henri, Jean-Luc Maria, Paul Lascombes, and Nicolas Heitz in Palaiseau, Ile-de-France, the company aims to revolutionize sectors such as telecommunications, earth observation, and space science. Exotrail's technology allows for greater flexibility in satellite deployment, enabling clients to access new orbits, extend operational lifespans, and optimize service performance. The company's focus on small satellite propulsion contributes to reducing space pollution while facilitating more effective satellite operations in orbit.

Eyevensys

Series B in 2020
Eyevensys is a address critical unmet needs in ophthalmology by providing a much better way of delivering ophthalmic drugs that overcomes the limitations of current options, such as intravitreal injections, surgery, intravitreal implants and biodegradable formulations. All of these current options have their drawbacks, given they are invasive procedures. Eyevensys’ goal is not only to improve short and long term therapeutic outcomes, but also to enhance compliance, improve ocular bioavailability and tolerability. They plan to build a high value product pipeline by enabling sustained production of therapeutic proteins in the eye that will deliver improved clinical outcomes while reducing the burden of frequent intravitreal or systemic injections and other invasive procedures.

Tallano

Series A in 2019
Tallano technologie is a pioneer in the field of particle emission reduction systems for vehicle braking.

UpFactor

Seed Round in 2019
UpFactor is an independent consultancy based in Paris, France, specializing in site analysis and large-scale detection of aerial land potential. Founded in 2017, the company utilizes a geographic information system that aggregates essential data for assessing building possibilities, including addresses, street widths, building heights, zoning regulations, solar land registers, and protected areas. UpFactor provides building heightening services that enable property owners to increase the number of floors on existing structures. This approach allows businesses to expand their usable space within already developed areas, promoting sustainable development while minimizing land use. The firm combines expertise in architecture, engineering, and law to support real estate and construction sectors effectively.

TISSIUM

Series B in 2019
TISSIUM is a privately owned medical device company based in Paris, France, focused on developing and commercializing innovative biodegradable sealants and adhesives for surgical wound closure, particularly in minimally invasive procedures. The company's products are designed to be non-toxic, bind effectively to tissues, and provide on-demand wound closure in the body’s dynamic environments. TISSIUM's technology is rooted in advanced research and intellectual property from renowned experts at MIT and Brigham & Women’s Hospital. The company aims to address various unmet clinical needs through its proprietary portfolio of fully biosynthetic, biomorphic, and programmable polymers. Founded in 2013, TISSIUM is supported by prominent healthcare investors, emphasizing its commitment to advancing surgical techniques through its groundbreaking solutions.

Incepto

Seed Round in 2019
Incepto is a developer of an artificial intelligence-based medical imaging platform aimed at addressing the challenges faced by healthcare professionals overwhelmed by patient volume and medical images. The platform offers advanced tools for interpreting computed tomography scans, chest x-rays, and detecting conditions such as fractures and bowel occlusions. Incepto specializes in creating AI-driven applications for mammogram screening and automated management of pulmonary nodules, facilitating enhanced patient care. The company's mission is to empower healthcare professionals by involving them in the AI production process through co-creation projects, ensuring that the tools developed meet the real needs of physicians and data scientists.

cozycozy.com

Venture Round in 2019
Cozycozy is a search engine that allows travelers to compare the full range of available accommodation options, ensuring that they find the place that best meets their needs and always at the best price. It allows users to search for all available accommodation options in one place, including hotels, apartments, houses, youth hostels, lodges, boats, tree houses, cottages, cabins, and more.

Implicity

Seed Round in 2019
Implicity is a developer of a remote monitoring platform that specializes in the smart monitoring of patients with connected cardiac devices, such as pacemakers and defibrillators. The platform utilizes artificial intelligence to sort and summarize patient data, assessing the criticality of alerts based on individual medical contexts. This capability allows cardiologists and healthcare professionals to automate the monitoring process, enabling them to effectively oversee patient health while consolidating information on a single platform. By streamlining remote monitoring, Implicity aims to enhance the quality of care provided to patients with cardiac implants.

Misakey

Seed Round in 2019
Misakey is a developer of personal data protection platform designed to manage digital life.The company's platform gives access to all the sites where personal data is present, recover the data from those sites, request for update, deletion, limitation and freezing of data, helping citizens claim back control over their personal data.

Admo.tv

Series B in 2019
Admo.tv is the best TV analytics platform that helps TV & radio advertisers to measure and optimise the online impact of their offline investments. Admo.tv optimises, in average, about 30% the R.O.I. of its clients by providing the finest analysis in terms of incremental visits and conversion of their media investments. Admo.tv is a start-up that has offices in Paris and operates in more than 12 different countries worldwide. Admo.tv optimise every day the offline investments of the best advertising agencies (Dentsu Aegis, Havas…) and top-tier brands such as Accor, Allianz, Ford, Meetic, La Redoute, and more.

Acticor Biotech

Series B in 2018
Acticor Biotech is a clinical-stage biopharmaceutical company based in Paris, France, founded in 2013. The company specializes in developing therapeutic monoclonal antibodies aimed at treating acute thrombotic diseases, particularly focusing on acute ischemic stroke. Its lead product, Glenzocimab, is a humanized antibody designed to address the urgent need for effective therapies in the acute phase of ischemic stroke, a condition that affects approximately 15 million people globally each year, leading to significant mortality and disability. Currently, there is a lack of effective treatment options, with existing therapies demonstrating limited efficacy and accessibility. Acticor Biotech seeks to provide innovative solutions to improve outcomes for stroke patients, addressing a critical gap in current medical care.

Acticor Biotech

Series B in 2018
Acticor Biotech is a clinical-stage biopharmaceutical company based in Paris, France, founded in 2013. The company specializes in developing therapeutic monoclonal antibodies aimed at treating acute thrombotic diseases, particularly focusing on acute ischemic stroke. Its lead product, Glenzocimab, is a humanized antibody designed to address the urgent need for effective therapies in the acute phase of ischemic stroke, a condition that affects approximately 15 million people globally each year, leading to significant mortality and disability. Currently, there is a lack of effective treatment options, with existing therapies demonstrating limited efficacy and accessibility. Acticor Biotech seeks to provide innovative solutions to improve outcomes for stroke patients, addressing a critical gap in current medical care.

Wisebatt

Seed Round in 2018
Wisebatt is a unique simulation tool for electronics engineers developing IoT devices. They can build virtual prototypes and collaborate to make the optimal choice between cost, battery life and performance, very early in the design cycle. Within minutes, hardware engineers access complex modeling results that would usually take weeks. Their technology leverages more than 15 years of academic research.

Wisebatt

Seed Round in 2018
Wisebatt is a unique simulation tool for electronics engineers developing IoT devices. They can build virtual prototypes and collaborate to make the optimal choice between cost, battery life and performance, very early in the design cycle. Within minutes, hardware engineers access complex modeling results that would usually take weeks. Their technology leverages more than 15 years of academic research.

TRiCares

Series B in 2018
TRiCares is a medical device company focused on creating a catheter-based valve replacement system aimed at the minimally invasive treatment of tricuspid valve regurgitation. The company's innovative medical devices are designed to address tricuspid insufficiency with a simplified approach that enhances usability. By prioritizing anatomical conformation, TRiCares seeks to provide patients with effective and lasting solutions for tricuspid valve issues, ultimately improving their health outcomes.

Serious Factory

Series A in 2018
Serious Factory is a publisher of innovative learning solutions for training purposes. Thanks to its expertise in instructional engineering and gamification, Serious Factory can help make your entire training programme genuinely effective: from acquiring knowledge (digital learning modules, Serious Games, blended learning and much more) and developing and strengthening skills (practical work, behavioural simulator, etc.) to updating content and monitoring skills from day to day.

Appscho

Seed Round in 2018
AppScho, SAS, established in 2014 and headquartered in Paris, France, specializes in mobile application software for higher education. Its application centralizes essential information for students and educational institutions, providing access to schedules, grades, school events, and employment opportunities. The app enhances student engagement by offering features such as course previews, classroom details, and notifications for schedule changes. Additionally, it facilitates communication between institutions and students, allowing educators to monitor student engagement and analyze performance. By streamlining campus content and services, AppScho aims to improve the overall academic experience and support students in managing their studies effectively.

Pherecydes Pharma

Series B in 2018
Pherecydes Pharma operator of an innovative biotechnologies company created to develop personalized phage therapy to treat bacterial infections. The company develops bacteriophages against infections and launched multicenter European phage therapy trial to evaluate phage therapy on infected burn wounds, recognize bacterial target attached to its outer membrane, inject genetic material and reproduce in the host to make new phages that get out and repeat the same cycle, enabling doctors to detect and treat people and their environment against a large range of biothreat agents, including multi-resistant, emergent or previously uncharacterized bacteria.

Acticor Biotech

Series A in 2018
Acticor Biotech is a clinical-stage biopharmaceutical company based in Paris, France, founded in 2013. The company specializes in developing therapeutic monoclonal antibodies aimed at treating acute thrombotic diseases, particularly focusing on acute ischemic stroke. Its lead product, Glenzocimab, is a humanized antibody designed to address the urgent need for effective therapies in the acute phase of ischemic stroke, a condition that affects approximately 15 million people globally each year, leading to significant mortality and disability. Currently, there is a lack of effective treatment options, with existing therapies demonstrating limited efficacy and accessibility. Acticor Biotech seeks to provide innovative solutions to improve outcomes for stroke patients, addressing a critical gap in current medical care.

Precogs

Venture Round in 2017
Precogs is a company based in Paris, France, founded in 2011, that specializes in business analytics solutions tailored for EMS-ODM-OEM sectors. The company offers a range of services, including supply risk management, enterprise resource planning (ERP), and procurement monitoring. Its key products feature CogWatch, a predictive tool leveraging big data, and Cog Margin, a platform designed for component pricing. Precogs focuses on providing real-time sourcing of electronic components, ensuring that clients receive competitive pricing for their needs.

PayinTech

Venture Round in 2017
PayinTech, founded in 2010 by Bertrand Sylvestre-Boncheval and Jean-Rémi Kouchakji, specializes in cashless payment solutions utilizing IoT technology. Initially developed for a student bar, the company expanded its offerings to include electronic wristbands and wireless payment terminals, enabling efficient transaction management at large events. Notably, PayinTech powered Europe's first fully cashless festival in 2012, serving 14,000 attendees. With significant funding raised in 2015 and 2017, the company has invested in research and development, allowing it to diversify its services across various private payment markets. PayinTech now operates in 16 countries, providing solutions to resorts, amusement parks, stadiums, and other organizations, enhancing their revenue while improving user experience and optimizing management costs. The company's goal remains to simplify transactional systems for corporate clients in the entertainment and tourism sectors.

Ugloo

Venture Round in 2017
Ugloo provides a robust data storage solution designed to enhance data security and management. The company offers a secondary storage platform that allows businesses to upgrade their existing infrastructure by creating virtual racks. This innovative approach enables efficient use of available space, eliminating the need for additional investments in physical storage while ensuring complete governance over data. Ugloo's solution facilitates the secure backup, sharing, and transmission of large files across various platforms, making it an essential tool for organizations seeking to protect vital information.

Nexdot

Venture Round in 2016
Nexdot specializes in the synthesis, production, and application of advanced semiconductor nanocrystals known as Quantum Dots (QDs), with a focus on nanoplatelets—two-dimensional nanosheet Quantum Dots that exhibit enhanced properties. Founded as a spin-off from a leading academic laboratory in Paris, Nexdot leverages over a decade of research in nanomaterials to create proprietary materials with controlled shape and composition. These innovations are poised to transform various industries, including displays, lighting, energy storage, detectors, and bio-imaging. Additionally, Nexdot is developing quantum pearl encapsulation technology to enhance the integration of quantum plates into existing production processes, thereby ensuring compliance with environmental regulations. The company is comprised of a dynamic team of skilled scientists and seasoned executives, dedicated to advancing innovation in the field of nanotechnology.

Restlet

Convertible Note in 2016
Restlet is a provider of an API-first Platform as a Service that enables both developers and non-developers to create, manage, and host APIs efficiently. Its comprehensive platform offers tools for designing, documenting, testing, and securing APIs, making it easier for enterprises to build and maintain cloud, mobile, web, and IoT applications. In addition to its platform, Restlet supports the API development community through the Restlet Framework, a widely used open-source REST API framework. The company aims to empower organizations to become API providers and participate in the global API-driven digital economy. Headquartered in San Mateo, California, with an engineering office in Nantes, France, Restlet is recognized for its innovative contributions to the API landscape.

TRiCares

Seed Round in 2016
TRiCares is a medical device company focused on creating a catheter-based valve replacement system aimed at the minimally invasive treatment of tricuspid valve regurgitation. The company's innovative medical devices are designed to address tricuspid insufficiency with a simplified approach that enhances usability. By prioritizing anatomical conformation, TRiCares seeks to provide patients with effective and lasting solutions for tricuspid valve issues, ultimately improving their health outcomes.

NAVYA

Series B in 2016
NAVYA is a leading French name in the autonomous vehicle market and in smart shared mobility solutions. With more than 200 employees in France (Paris and Lyon) and in the United States (Michigan), NAVYA develops, manufactures and commercializes autonomous, driverless, and electric vehicles that combine robotic, digital and driving technologies at the highest level. Since 2015, NAVYA has been the first to market and put into service autonomous mobility solutions, shuttles and cabs. NAVYA has a range of two autonomous vehicles: the AUTONOM®SHUTTLE, launched in September 2015, of which more than 100 have already been produced as of today and 89 sold in 17 countries as of June 30, 2018, notably in the United States, France, Germany, Switzerland, Japan and Australia, and the AUTONOM®CAB, unveiled in November 2017 and whose first road tests will start shortly.

Stootie

Series A in 2016
Stootie is a mobile classifieds platform that focuses on facilitating peer-to-peer transactions in real time, primarily within local communities. It serves as a convenient tool for users to quickly find and offer various items or services, catering to immediate needs, such as locating a phone charger while at a café. Available on both iOS and Android, Stootie has established itself as a leading app for peer-to-peer services in France. In addition to general classifieds, the platform also offers information, advice, and tips related to living spaces, DIY projects, gardening, and home decoration, making it a versatile resource for users seeking assistance in various areas of everyday life.

Playtem

Venture Round in 2016
Playtem is a video game monetization platform that aims to bridge the gap between gamers and their favorite brands through innovative in-game native advertising formats. The company focuses on creating emotional connections between players and brands, facilitating daily engagement across web and mobile platforms. By prioritizing impactful advertising that enhances user experience, Playtem seeks to revolutionize the future of advertising in the gaming industry. The team, comprised of passionate entrepreneurs, is dedicated to developing solutions that benefit both brands and gamers alike.

Comiteo

Venture Round in 2016
Comitéo, established in 2008, specializes in providing innovative services tailored for works councils through a business productivity software platform. The company focuses on simplifying daily management and enhancing communication within organizations. Its web platform and mobile application are highly configurable, enabling access to technology, culture, recreation, and management tools. Comitéo's software not only facilitates effective communication but also offers employees exceptional promotions from various brands, thereby contributing to employee satisfaction. Additionally, the platform assists clients in managing accounting and budgeting for works councils, ultimately supporting both employee well-being and organizational growth.

Nexdot

Venture Round in 2016
Nexdot specializes in the synthesis, production, and application of advanced semiconductor nanocrystals known as Quantum Dots (QDs), with a focus on nanoplatelets—two-dimensional nanosheet Quantum Dots that exhibit enhanced properties. Founded as a spin-off from a leading academic laboratory in Paris, Nexdot leverages over a decade of research in nanomaterials to create proprietary materials with controlled shape and composition. These innovations are poised to transform various industries, including displays, lighting, energy storage, detectors, and bio-imaging. Additionally, Nexdot is developing quantum pearl encapsulation technology to enhance the integration of quantum plates into existing production processes, thereby ensuring compliance with environmental regulations. The company is comprised of a dynamic team of skilled scientists and seasoned executives, dedicated to advancing innovation in the field of nanotechnology.

Restlet

Convertible Note in 2016
Restlet is a provider of an API-first Platform as a Service that enables both developers and non-developers to create, manage, and host APIs efficiently. Its comprehensive platform offers tools for designing, documenting, testing, and securing APIs, making it easier for enterprises to build and maintain cloud, mobile, web, and IoT applications. In addition to its platform, Restlet supports the API development community through the Restlet Framework, a widely used open-source REST API framework. The company aims to empower organizations to become API providers and participate in the global API-driven digital economy. Headquartered in San Mateo, California, with an engineering office in Nantes, France, Restlet is recognized for its innovative contributions to the API landscape.

Bnbsitter

Series A in 2016
Bnbsitter is a Paris-based company established in 2013 that specializes in concierge rental services for vacation hosts. It provides a user-friendly online platform that allows hosts to easily book essential services for their guests, such as check-in/check-out assistance and rental cleaning, all within a matter of minutes. Bnbsitter caters to hosts who may be busy, traveling, or otherwise unable to personally welcome their guests, ensuring that visitors receive a warm greeting upon arrival. The company also offers additional services related to property management, including maintenance and inventory management, streamlining the rental experience for both hosts and guests. As of January 2020, Bnbsitter operates as a subsidiary of checkmyguest.

TISSIUM

Series A in 2016
TISSIUM is a privately owned medical device company based in Paris, France, focused on developing and commercializing innovative biodegradable sealants and adhesives for surgical wound closure, particularly in minimally invasive procedures. The company's products are designed to be non-toxic, bind effectively to tissues, and provide on-demand wound closure in the body’s dynamic environments. TISSIUM's technology is rooted in advanced research and intellectual property from renowned experts at MIT and Brigham & Women’s Hospital. The company aims to address various unmet clinical needs through its proprietary portfolio of fully biosynthetic, biomorphic, and programmable polymers. Founded in 2013, TISSIUM is supported by prominent healthcare investors, emphasizing its commitment to advancing surgical techniques through its groundbreaking solutions.

Melusyn

Seed Round in 2016
Melusyn offers an interactive platform that enables film product crews to keep track of and optimize their schedules. It enables teams to communicate with each other; keep track of decorations, casting, and costumes; keep track of time; and more. Melusyn is based in Paris, France.

NAVYA

Venture Round in 2016
NAVYA is a leading French name in the autonomous vehicle market and in smart shared mobility solutions. With more than 200 employees in France (Paris and Lyon) and in the United States (Michigan), NAVYA develops, manufactures and commercializes autonomous, driverless, and electric vehicles that combine robotic, digital and driving technologies at the highest level. Since 2015, NAVYA has been the first to market and put into service autonomous mobility solutions, shuttles and cabs. NAVYA has a range of two autonomous vehicles: the AUTONOM®SHUTTLE, launched in September 2015, of which more than 100 have already been produced as of today and 89 sold in 17 countries as of June 30, 2018, notably in the United States, France, Germany, Switzerland, Japan and Australia, and the AUTONOM®CAB, unveiled in November 2017 and whose first road tests will start shortly.

Restlet

Convertible Note in 2015
Restlet is a provider of an API-first Platform as a Service that enables both developers and non-developers to create, manage, and host APIs efficiently. Its comprehensive platform offers tools for designing, documenting, testing, and securing APIs, making it easier for enterprises to build and maintain cloud, mobile, web, and IoT applications. In addition to its platform, Restlet supports the API development community through the Restlet Framework, a widely used open-source REST API framework. The company aims to empower organizations to become API providers and participate in the global API-driven digital economy. Headquartered in San Mateo, California, with an engineering office in Nantes, France, Restlet is recognized for its innovative contributions to the API landscape.

MOPeasy

Venture Round in 2015
MOPeasy, ecomobility operator, provides solutions for car sharing of electric vehicules and others, car pooling and access and reservations for charging stations, all in one platform. THE community solution adapted to companies, cities and collective habitats. MOPeasy turns charging stations into mobility stations, operates from 1 to 50 vehicules fleet for a Company. and from 1 station in Rural Communities up to 100 stations across a territory. Interoperable, MOPeasy's platform brings ecomobility solutions for Smart cities.

NAVYA

Seed Round in 2015
NAVYA is a leading French name in the autonomous vehicle market and in smart shared mobility solutions. With more than 200 employees in France (Paris and Lyon) and in the United States (Michigan), NAVYA develops, manufactures and commercializes autonomous, driverless, and electric vehicles that combine robotic, digital and driving technologies at the highest level. Since 2015, NAVYA has been the first to market and put into service autonomous mobility solutions, shuttles and cabs. NAVYA has a range of two autonomous vehicles: the AUTONOM®SHUTTLE, launched in September 2015, of which more than 100 have already been produced as of today and 89 sold in 17 countries as of June 30, 2018, notably in the United States, France, Germany, Switzerland, Japan and Australia, and the AUTONOM®CAB, unveiled in November 2017 and whose first road tests will start shortly.

Mitricares

Seed Round in 2015
MITRICARES aims to develop and market an implantable medical device for percutaneous treatment of tricuspid valves failed. The young company has already realized a first prototype successfully tested several times on the big animal. This new system would address a major public health problem, tricuspid insufficiency, which affects 4 million people in Europe and the USA, with a poor prognosis in the short term.

Aterovax

Seed Round in 2015
Aterovax is an in vitro diagnostic (IVD) company that develops innovative solutions to predict, diagnose and prevent cardiovascular disease through its Unique understanding of atherosclerosis.

TRiCares

Seed Round in 2015
TRiCares is a medical device company focused on creating a catheter-based valve replacement system aimed at the minimally invasive treatment of tricuspid valve regurgitation. The company's innovative medical devices are designed to address tricuspid insufficiency with a simplified approach that enhances usability. By prioritizing anatomical conformation, TRiCares seeks to provide patients with effective and lasting solutions for tricuspid valve issues, ultimately improving their health outcomes.

Prestodiag

Series A in 2015
Prestodiag specializes in the development, manufacturing, and sale of innovative solutions for the rapid detection of pathogenic bacteria. Utilizing advanced Surface Plasmon Resonance imaging technology, the company offers analytical solutions that can identify harmful bacteria such as Salmonella, Listeria, and E. coli within hours, significantly reducing the time required for results compared to traditional methods. Prestodiag primarily serves the food safety sector but also addresses medical and environmental applications. By enabling the early detection of multiple pathogens in complex samples, their systems assist businesses in enhancing the shelf life of products and ensuring safety in food and healthcare environments.

Eyevensys

Seed Round in 2015
Eyevensys is a address critical unmet needs in ophthalmology by providing a much better way of delivering ophthalmic drugs that overcomes the limitations of current options, such as intravitreal injections, surgery, intravitreal implants and biodegradable formulations. All of these current options have their drawbacks, given they are invasive procedures. Eyevensys’ goal is not only to improve short and long term therapeutic outcomes, but also to enhance compliance, improve ocular bioavailability and tolerability. They plan to build a high value product pipeline by enabling sustained production of therapeutic proteins in the eye that will deliver improved clinical outcomes while reducing the burden of frequent intravitreal or systemic injections and other invasive procedures.

Melusyn

Seed Round in 2015
Melusyn offers an interactive platform that enables film product crews to keep track of and optimize their schedules. It enables teams to communicate with each other; keep track of decorations, casting, and costumes; keep track of time; and more. Melusyn is based in Paris, France.

RED Technologies

Seed Round in 2015
RED Technologies specializes in spectrum sharing technologies aimed at addressing the growing demand for accessible and affordable 5G services. The company develops cloud-based solutions that facilitate dynamic spectrum access for private 5G networks, allowing operators to modernize their communication infrastructures effectively. RED’s innovative spectrum access system operates within a three-tier hierarchy, enabling clients to implement proper sharing and protection for users in a multi-tiered spectrum sharing environment. Additionally, RED Technologies is engaged in regulatory developments and standardization efforts to further enhance the accessibility of 5G services.

English Attack

Series A in 2015
English Attack is a Web 2.0, entertainment-driven English language learning Entertainment Learning was created to bring leverage the power of digital entertainment to transform the way people learn. Its flagship service, English Attack! (www.english-attack.com) creates true innovation in the $35 billion market for English language learning via a 100% entertainment-driven approach to helping learners increase and enhance their exposure to, and use of, the language. It achieves this via interactive lessons based on clips from blockbuster movies, hit TV series, and television news reports; chart-topping music videos; professionally produced casual games; visual dictionaries; and a global social network of learners of English. Entertainment Learning was founded by experienced digital entertainment executives Paul Maglione and Frederic Tibout, who launched English Attack! commercially in 2012 after the service had won or been a finalist in several French and European startup competitions including Plugg Brussels, The Next Web Amsterdam, and Seedcamp Paris.

Serious Factory

Seed Round in 2015
Serious Factory is a publisher of innovative learning solutions for training purposes. Thanks to its expertise in instructional engineering and gamification, Serious Factory can help make your entire training programme genuinely effective: from acquiring knowledge (digital learning modules, Serious Games, blended learning and much more) and developing and strengthening skills (practical work, behavioural simulator, etc.) to updating content and monitoring skills from day to day.

VitamFero

Series C in 2015
Incorporated in late 2005, VitamFero SA is a privately held biotech company whose mission, founded on an innovative and patented technology (i.e. Toxo KO), is to create, develop, register and market novel anti-infectious vaccines, first against Apicomplexe parasites such as: - Toxoplasma gondii (toxoplasmosis agent) - Neospora caninum (neosporosis agent) - Cryptosporidium parvum (cryptosporidiosis agent). With headquarters in Evry (France) and laboratories in Tours (France), VitamFero is involved first in veterinary healthcare.

PayinTech

Seed Round in 2015
PayinTech, founded in 2010 by Bertrand Sylvestre-Boncheval and Jean-Rémi Kouchakji, specializes in cashless payment solutions utilizing IoT technology. Initially developed for a student bar, the company expanded its offerings to include electronic wristbands and wireless payment terminals, enabling efficient transaction management at large events. Notably, PayinTech powered Europe's first fully cashless festival in 2012, serving 14,000 attendees. With significant funding raised in 2015 and 2017, the company has invested in research and development, allowing it to diversify its services across various private payment markets. PayinTech now operates in 16 countries, providing solutions to resorts, amusement parks, stadiums, and other organizations, enhancing their revenue while improving user experience and optimizing management costs. The company's goal remains to simplify transactional systems for corporate clients in the entertainment and tourism sectors.

Stootie

Seed Round in 2015
Stootie is a mobile classifieds platform that focuses on facilitating peer-to-peer transactions in real time, primarily within local communities. It serves as a convenient tool for users to quickly find and offer various items or services, catering to immediate needs, such as locating a phone charger while at a café. Available on both iOS and Android, Stootie has established itself as a leading app for peer-to-peer services in France. In addition to general classifieds, the platform also offers information, advice, and tips related to living spaces, DIY projects, gardening, and home decoration, making it a versatile resource for users seeking assistance in various areas of everyday life.

Open Ocean

Seed Round in 2015
Open Ocean SAS is a company that specializes in developing a SaaS-based decision-making platform focused on managing offshore infrastructure and marine operations. Founded in 2011 and headquartered in Paris and Brest, the company offers a range of products and services, including the Metocean Analytics solution, which analyzes atmospheric and oceanic conditions, and a detailed report on the tidal energy market in France. Additionally, Open Ocean provides a spectral wave database for Scotland, facilitating the development of marine renewable energy. Its services encompass site data analysis, resource and energy assessment, environmental data for design calculations, and research and development for offshore energy projects. Open Ocean caters to farm developers, operators, and public agencies within the renewable marine energy sector, leveraging a highly qualified team of oceanographers skilled in high-resolution modeling and data analysis.

Pherecydes Pharma

Series A in 2014
Pherecydes Pharma operator of an innovative biotechnologies company created to develop personalized phage therapy to treat bacterial infections. The company develops bacteriophages against infections and launched multicenter European phage therapy trial to evaluate phage therapy on infected burn wounds, recognize bacterial target attached to its outer membrane, inject genetic material and reproduce in the host to make new phages that get out and repeat the same cycle, enabling doctors to detect and treat people and their environment against a large range of biothreat agents, including multi-resistant, emergent or previously uncharacterized bacteria.

Restlet

Convertible Note in 2014
Restlet is a provider of an API-first Platform as a Service that enables both developers and non-developers to create, manage, and host APIs efficiently. Its comprehensive platform offers tools for designing, documenting, testing, and securing APIs, making it easier for enterprises to build and maintain cloud, mobile, web, and IoT applications. In addition to its platform, Restlet supports the API development community through the Restlet Framework, a widely used open-source REST API framework. The company aims to empower organizations to become API providers and participate in the global API-driven digital economy. Headquartered in San Mateo, California, with an engineering office in Nantes, France, Restlet is recognized for its innovative contributions to the API landscape.

Web Geo Services

Seed Round in 2014
Web Geo Services SAS, established in 2009 and headquartered in Montpellier, France, specializes in online mapping and location-based applications. The company focuses on providing location SaaS technology for various sectors, including retail, e-commerce, travel, hospitality, banking, insurance, automotive, and mobility. By leveraging Google Maps, Web Geo Services assists businesses in enhancing customer engagement and driving conversions through digital systems that streamline online checkouts and customer journeys. With a client base of over 400 large companies, it has positioned itself as a leading partner of Google Cloud and the foremost Google Maps partner in Europe, with offices in multiple countries. The company has developed Woosmap, an award-winning platform that enables developers to integrate advanced location intelligence features into mobile applications and websites, thereby offering businesses a competitive edge in their respective markets.

Playtem

Venture Round in 2014
Playtem is a video game monetization platform that aims to bridge the gap between gamers and their favorite brands through innovative in-game native advertising formats. The company focuses on creating emotional connections between players and brands, facilitating daily engagement across web and mobile platforms. By prioritizing impactful advertising that enhances user experience, Playtem seeks to revolutionize the future of advertising in the gaming industry. The team, comprised of passionate entrepreneurs, is dedicated to developing solutions that benefit both brands and gamers alike.

Precogs

Seed Round in 2014
Precogs is a company based in Paris, France, founded in 2011, that specializes in business analytics solutions tailored for EMS-ODM-OEM sectors. The company offers a range of services, including supply risk management, enterprise resource planning (ERP), and procurement monitoring. Its key products feature CogWatch, a predictive tool leveraging big data, and Cog Margin, a platform designed for component pricing. Precogs focuses on providing real-time sourcing of electronic components, ensuring that clients receive competitive pricing for their needs.

Rool'in

Seed Round in 2014
Rool'in offers innovative, practical and ecological solutions in the field of bicycle mobility.

Neelogy

Seed Round in 2013
Neelogy develops and markets non-remanence magnetic sensors (thus very precise and non-intrusive) for the measurement of alternating and continuous electrical currents. The company's mission: to meet new needs related to energy metering, AC / DC energy conversion, electrical energy storage, real-time fault detection and diagnostics.

Axess Vision Technology

Series B in 2013
Axess Vision Technology S.A. is a French company specializing in the design and production of disposable sterile endoscopes for various medical applications, including bronchoscopy and urology. Founded in 2006 and headquartered in Saint-Pierre-des-Corps, the firm has dedicated significant resources to research and development, culminating in the commercialization of its first single-use endoscope in 2014. With a focus on patient safety and comfort, Axess Vision Technology aims to enhance the efficiency of medical practitioners while addressing emerging health challenges. The company has introduced several innovative products, backed by collaboration with medical experts and a commitment to sustainability and community engagement. Through its ongoing efforts, Axess Vision has secured multiple patents and continues to prioritize innovation in the evolving healthcare landscape.

TISSIUM

Series A in 2013
TISSIUM is a privately owned medical device company based in Paris, France, focused on developing and commercializing innovative biodegradable sealants and adhesives for surgical wound closure, particularly in minimally invasive procedures. The company's products are designed to be non-toxic, bind effectively to tissues, and provide on-demand wound closure in the body’s dynamic environments. TISSIUM's technology is rooted in advanced research and intellectual property from renowned experts at MIT and Brigham & Women’s Hospital. The company aims to address various unmet clinical needs through its proprietary portfolio of fully biosynthetic, biomorphic, and programmable polymers. Founded in 2013, TISSIUM is supported by prominent healthcare investors, emphasizing its commitment to advancing surgical techniques through its groundbreaking solutions.

Aterovax

Seed Round in 2013
Aterovax is an in vitro diagnostic (IVD) company that develops innovative solutions to predict, diagnose and prevent cardiovascular disease through its Unique understanding of atherosclerosis.

Restlet

Seed Round in 2013
Restlet is a provider of an API-first Platform as a Service that enables both developers and non-developers to create, manage, and host APIs efficiently. Its comprehensive platform offers tools for designing, documenting, testing, and securing APIs, making it easier for enterprises to build and maintain cloud, mobile, web, and IoT applications. In addition to its platform, Restlet supports the API development community through the Restlet Framework, a widely used open-source REST API framework. The company aims to empower organizations to become API providers and participate in the global API-driven digital economy. Headquartered in San Mateo, California, with an engineering office in Nantes, France, Restlet is recognized for its innovative contributions to the API landscape.

AlephD

Series A in 2013
AlephD specializes in providing real-time bidding solutions for online publishers, enhancing their revenue generation capabilities. Founded in 2012 by a former executive from Criteo and two experienced data scientists, the company offers innovative algorithms that predict auction performance just before each impression is served. By applying these algorithms to billions of auction logs, AlephD can optimize selling strategies to attract the most relevant buyers at optimal prices, resulting in potential revenue increases of up to 30% for its clients. The company's technology includes InstantPredict and InventoryLab, which integrate data analysis and business intelligence tools to support publishers in their decision-making processes. AlephD aims to equip publishers with advanced technological capabilities similar to those of top-tier advertisers, fostering a more equitable environment in the real-time bidding market and creating new opportunities for both buyers and sellers.

Fidzup

Seed Round in 2013
Fidzup is a Paris-based company that offers web-oriented tools tailored for brick-and-mortar businesses. Established in 2013, it has developed a distinctive in-store analytics platform that enables retailers to retarget customers with personalized mobile advertisements. By integrating Wi-Fi and GPS technology, Fidzup's local marketing platform tracks the behavior of mobile users both at the point of sale and in surrounding areas. This capability allows retailers to gather valuable data on consumer behavior, analyze it effectively, and deliver targeted advertisements directly to customers’ mobile devices, thereby enhancing local market engagement.

Fidzup

Angel Round in 2013
Fidzup is a Paris-based company that offers web-oriented tools tailored for brick-and-mortar businesses. Established in 2013, it has developed a distinctive in-store analytics platform that enables retailers to retarget customers with personalized mobile advertisements. By integrating Wi-Fi and GPS technology, Fidzup's local marketing platform tracks the behavior of mobile users both at the point of sale and in surrounding areas. This capability allows retailers to gather valuable data on consumer behavior, analyze it effectively, and deliver targeted advertisements directly to customers’ mobile devices, thereby enhancing local market engagement.

Nanoe

Seed Round in 2013
Nanoe is a manufacturer specializing in nanopowders designed for the technical ceramics market. The company focuses on producing nano-scale ceramics, particularly alumina, zirconia, and zirconia toughened alumina. By offering ready-to-sinter nano-powders, Nanoe enables manufacturers to access high-quality materials that leverage the advantages of nanotechnology in advanced ceramics manufacturing, all at a competitive price.

e(ye)BRAIN

Series B in 2012
e(ye)BRAIN is a medical company that manufactures and distributes eye trackers for its clients. e(ye)BRAIN’s range of products include Eye Brain T1 and T2. The T1 enables its users to record eye movements. T2 uses algorithms to enable its users to record eye and head movements. The recorded movements will be analyzed by a software called MeyeEval. The company offers advisory, paradigm development, formation, and support services to its clients. e(ye)BRAIN was founded in 2008 by Serge Kinkingnehun and is based in France.

WeCook WeCare

Seed Round in 2012
WeCook WeCare provides a customized program focused on weight management and improving quality of life. The platform offers culinary and nutritional information services that help users plan their meals effectively. By subscribing to the service, users receive weekly meal plans curated from a diverse selection of menus, which supports their weight loss goals and enhances their overall well-being. Through this approach, WeCook WeCare addresses the challenges associated with dieting and aims to facilitate a healthier lifestyle.

PlasmaBiotics

Seed Round in 2012
PlasmaBiotics is a biotechnology company based in Evry, France, that specializes in designing, manufacturing, and marketing cold plasma nitrogen generators for medical disinfection. Founded in 2011, the company aims to enhance hospital efficiency and reduce the risk of bacterial contamination through its innovative products, including the PlasmaTYPHOON and PlasmaBAG. These devices utilize a patented technology developed by the National French Research Center, allowing for disinfection of medical equipment at ambient temperature and pressure. As a subsidiary of HOYA Corporation since August 2018, PlasmaBiotics continues to focus on providing effective solutions for the medical industry.

Green Point SAS

Seed Round in 2012
GreenPoint specialises in regtech, namely in digital and mobile management of know your customer (KYC), digital processing of customers’ records and customer on-boarding.

PlasmaBiotics

Acquisition in 2012
PlasmaBiotics is a biotechnology company based in Evry, France, that specializes in designing, manufacturing, and marketing cold plasma nitrogen generators for medical disinfection. Founded in 2011, the company aims to enhance hospital efficiency and reduce the risk of bacterial contamination through its innovative products, including the PlasmaTYPHOON and PlasmaBAG. These devices utilize a patented technology developed by the National French Research Center, allowing for disinfection of medical equipment at ambient temperature and pressure. As a subsidiary of HOYA Corporation since August 2018, PlasmaBiotics continues to focus on providing effective solutions for the medical industry.

VitamFero

Seed Round in 2011
Incorporated in late 2005, VitamFero SA is a privately held biotech company whose mission, founded on an innovative and patented technology (i.e. Toxo KO), is to create, develop, register and market novel anti-infectious vaccines, first against Apicomplexe parasites such as: - Toxoplasma gondii (toxoplasmosis agent) - Neospora caninum (neosporosis agent) - Cryptosporidium parvum (cryptosporidiosis agent). With headquarters in Evry (France) and laboratories in Tours (France), VitamFero is involved first in veterinary healthcare.

EVIAGENICS

Series A in 2011
EVIAGENICS is a biotechnology company generating new products and improved manufacturing processes for the chemical and pharmaceutical industry by applying its unique in vivo recombination technology. After the successful validation of the technology in several collaborations with industrial partners from red and white biotechnology EVIAGENICS will focus its activities on the development of a technology platform for the efficient recombination and expression of metabolic pathways in cells. These reprogrammed cells will be able to transform sugars from cheap renewable sources like feedstock into numerous new high value compounds.

Edenwall Technologies

Seed Round in 2010
Edenwall is a security vendor of identity-based firewall connection filtering solutions.

Physikron

Seed Round in 2010
Physikron is a company focused on the development of advanced mass spectrometry technologies that enhance the performance of tandem spectrometry. Its innovations in proteomic analysis significantly increase the identification of peptides and proteins during liquid chromatography coupled with mass spectrometry acquisitions. By improving the efficiency and effectiveness of these analyses, Physikron enables researchers to conduct more comprehensive studies in their respective fields.

Nanobiotix

Series C in 2010
Nanobiotix SA develops nanomedicine programs for the treatment of cancer. The company provides NanoXray that offers a solution for cancer therapy based on a technology that is designed to allow destruction of cancer cells by inert particles. Its products include magnetic particles and laser activated nanoparticles for the treatment and diagnostic of cancer.

e(ye)BRAIN

Series A in 2009
e(ye)BRAIN is a medical company that manufactures and distributes eye trackers for its clients. e(ye)BRAIN’s range of products include Eye Brain T1 and T2. The T1 enables its users to record eye movements. T2 uses algorithms to enable its users to record eye and head movements. The recorded movements will be analyzed by a software called MeyeEval. The company offers advisory, paradigm development, formation, and support services to its clients. e(ye)BRAIN was founded in 2008 by Serge Kinkingnehun and is based in France.

Neelogy

Acquisition in 2009
Neelogy develops and markets non-remanence magnetic sensors (thus very precise and non-intrusive) for the measurement of alternating and continuous electrical currents. The company's mission: to meet new needs related to energy metering, AC / DC energy conversion, electrical energy storage, real-time fault detection and diagnostics.

InnaVirVax

Series A in 2009
InnaVirVax is a privately-owned biopharmaceutical company dedicated to the development of a cutting edge discovery in the field of therapy/prevention and prognostic of AIDS and HIV infection, other infectious diseases, and new cancer therapies.

Up & Net

Series B in 2009
Up&Net SAS develops gift card solutions used on ecommerce sites. The company also publishes Cadeaux-avenue.com, a gateway for gifts; and Monblogshopping.com, a platform of blogs dedicated to shopping. Up&Net SAS was incorporated in 2005 and is based in Paris, France.

Sesamea

Series A in 2008
Sesamea is a French company that specializes in providing electronic gift and cash cards, which can be redeemed at various e-commerce stores and retailers. The company operates an online platform that allows users to purchase tailor-made gift cards, facilitating payments for a wide range of products available at partner stores and online shopping sites. Through its services, Sesamea aims to enhance the gifting experience by offering convenient and versatile payment solutions for consumers.

Advestigo

Series B in 2008
Advestigo S.A., a technology company, provides digital assets protection solutions. It offers theraography technology, which analyses digital content to generate content-based fingerprints; AdvestiCHECK, a software package that allows companies to monitor information technology networks and workstations; and AdvestiGUARD, a software package that allows companies to monitor communication channels. The company was founded in 2002 and is based in Saint-Cloud, France. As of March 9, 2009, Advestigo S.A. operates as a subsidiary of Hologram Industries SA.

Codasystem

Venture Round in 2008
Codasystem is a French start-up specializing in digital photography technology that holds legal value. The company provides a real-time monitoring tool that enables users to capture digital photographs using their mobile phones, which can be utilized as legally admissible evidence. This innovative approach enhances the reliability of visual documentation, catering to various sectors that require verifiable photographic records.

WatchFrog

Series A in 2008
WatchFrog's versatile technology derives from a fundamental research program carried out within an internationally recognized research laboratory affiliated to the CNRS (National Research Council) and located within the French Natural History Museum. WatchFrog has been granted a 450.000 euros award from the French Ministry of Research for its innovative activity and technology.

Idylis

Series B in 2007
Idylis S.A. designs, develops, and markets software solutions for enterprise management. Its products assist in audit and accounting, financial management, documentation, e-mailing, and scheduling applications. The company also offers solutions for commercial applications such as supply chain management, logistics, and inventory management. In addition, it provides customer support and consulting services to its clients. The company was incorporated in 2008 and is based in Issy-les-Moulineaux, France.

Voluntis

Venture Round in 2007
Voluntis, Inc. is a healthcare software company headquartered in Cambridge, Massachusetts, that specializes in developing digital therapeutic solutions for various medical conditions, including diabetes and oncology. Founded in 2001, Voluntis provides innovative tools such as Insulia, which offers personalized insulin dose recommendations for type 2 diabetes patients, and Diabeo, designed for type 1 and type 2 patients on basal-bolus insulin regimens. These solutions utilize algorithmic calculations tailored to individual patient needs, incorporating real-time data like blood glucose levels. The company aims to enhance patient monitoring and support by leveraging advanced information and communication technologies. With over 600,000 patients managed and more than 50 programs deployed, Voluntis emphasizes a patient-centric approach to healthcare, striving to improve medical outcomes and healthcare system efficiency through its digital health solutions.

erytech

Venture Round in 2006
ERYtech Pharma specializes in the encapsulation of therapeutic molecules and enzymes in red blood cells. It has achieved a major breakthrough in the fields of cancer and enzyme therapy by significantly increasing the therapeutic index of the encapsulated molecule or enzyme.

Codasystem

Series A in 2006
Codasystem is a French start-up specializing in digital photography technology that holds legal value. The company provides a real-time monitoring tool that enables users to capture digital photographs using their mobile phones, which can be utilized as legally admissible evidence. This innovative approach enhances the reliability of visual documentation, catering to various sectors that require verifiable photographic records.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.